Citadel Advisors’s Option Care Health OPCH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$471K Sell
17,500
-23,300
-57% -$756K ﹤0.01% 9449
2025
Q4
$1.3M Sell
40,800
-7,100
-15% -$208K ﹤0.01% 6835
2025
Q3
$1.33M Sell
47,900
-16,900
-26% -$489K ﹤0.01% 6920
2025
Q2
$2.1M Sell
64,800
-59,500
-48% -$1.92M ﹤0.01% 5613
2025
Q1
$4.34M Buy
124,300
+59,500
+92% +$1.87M ﹤0.01% 4112
2024
Q4
$1.5M Buy
64,800
+35,800
+123% +$905K ﹤0.01% 6222
2024
Q3
$908K Buy
29,000
+1,900
+7% +$58.3K ﹤0.01% 7062
2024
Q2
$751K Sell
27,100
-1,300
-5% -$38.7K ﹤0.01% 7200
2024
Q1
$953K Buy
28,400
+23,400
+468% +$757K ﹤0.01% 7012
2023
Q4
$168K Sell
5,000
-57,000
-92% -$1.75M ﹤0.01% 10214
2023
Q3
$2.01M Buy
62,000
+500
+0.8% +$16.9K ﹤0.01% 5204
2023
Q2
$2M Buy
61,500
+57,000
+1,267% +$1.72M ﹤0.01% 5151
2023
Q1
$143K Sell
4,500
-1,000
-18% -$30K ﹤0.01% 10720
2022
Q4
$165K Sell
5,500
-7,000
-56% -$217K ﹤0.01% 10450
2022
Q3
$393K Buy
+12,500
New +$400K ﹤0.01% 8982
2021
Q4
Sell
-32,600
Closed -$791K 14465
2021
Q3
$791K Buy
32,600
+10,800
+50% +$251K ﹤0.01% 8733
2021
Q2
$477K Sell
21,800
-14,200
-39% -$274K ﹤0.01% 10160
2021
Q1
$639K Buy
36,000
+1,300
+4% +$24.4K ﹤0.01% 9139
2020
Q4
$543K Buy
+34,700
New +$516K ﹤0.01% 7985
2016
Q2
Sell
-2,725
Closed -$23K 7231
2016
Q1
$23K Buy
2,725
+1,550
+132% +$11.6K ﹤0.01% 6434
2015
Q4
$8K Sell
1,175
-5,175
-81% -$41.3K ﹤0.01% 8344
2015
Q3
$47K Sell
6,350
-6,125
-49% -$61.9K ﹤0.01% 7629
2015
Q2
$181K Buy
12,475
+8,575
+220% +$145K ﹤0.01% 6450
2015
Q1
$69K Buy
3,900
+2,500
+179% +$54.6K ﹤0.01% 7160
2014
Q4
$39K Sell
1,400
-25
-2% -$620 ﹤0.01% 7384
2014
Q3
$39K Sell
1,425
-1,550
-52% -$48.1K ﹤0.01% 7062
2014
Q2
$99K Sell
2,975
-1,300
-30% -$39.1K ﹤0.01% 6235
2014
Q1
$119K Buy
4,275
+3,125
+272% +$96.5K ﹤0.01% 6028
2013
Q4
$34K Buy
+1,150
New +$32.5K ﹤0.01% 6231

Other funds holding OPCH

Citadel Advisors's OPCH Position: Q1 2026 in Review

Citadel Advisors increased its Option Care Health (OPCH) stake by 111% in Q1 2026, buying an estimated $60.5M and bringing the position to 3,537,458 shares worth $95.2M. The position accounts for 0.02% of the portfolio, ranked #841.

Citadel Advisors first reported a position in OPCH in Q4 2013 and has held it in 42 quarters since. The position peaked at $160M in Q1 2023. 370 funds tracked by Wall St. Rank hold OPCH as of Q1 2026.

  • Citadel Advisors held 3,537,458 shares of Option Care Health worth $95.2M as of Q1 2026.
  • Citadel Advisors bought 1,863,912 Option Care Health shares in Q1 2026, an estimated $60.5M.
  • Option Care Health made up 0.02% of Citadel Advisors's portfolio in Q1 2026, its #841 holding.
  • Citadel Advisors first reported a position in Option Care Health in Q4 2013 and has held it in 42 quarters since.
  • Citadel Advisors's Option Care Health position peaked at $160M in Q1 2023.
  • 370 funds tracked by Wall St. Rank held Option Care Health as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.